tetraethylammonium has been researched along with Raynaud Disease in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DI CIO, AV | 1 |
| LISTA, GA | 1 |
1 other study available for tetraethylammonium and Raynaud Disease
| Article | Year |
|---|---|
[Treatment of diseases of the peripheral arteries with tetraethylammonium chloride].
Topics: Ammonia; Ammonium Compounds; Arteries; Cardiovascular System; Endarteritis; Quaternary Ammonium Comp | 1950 |